1. Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4
   Aruni Ghose et al, 2024, Therapeutic Advances in Medical Oncology CrossRef
2. Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells
   Nguyen-Tuong Ho et al, 2022, International Journal of Molecular Sciences CrossRef
3. Osteopontin and Cancer: Insights into Its Role in Drug Resistance
   Chengcheng Hao et al, 2023, Biomedicines CrossRef
4. P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators
   Yang Guo et al, 2024, Drug Discovery Today CrossRef
5. Meta-analysis of Osteopontin splice variants in cancer
   Yu An et al, 2023, BMC Cancer CrossRef
6. Cisplatin for cancer therapy and overcoming chemoresistance
   Ranmali Ranasinghe et al, 2022, Heliyon CrossRef
7. Interplay Between Thiamine and p53/p21 Axes Affects Antiproliferative Action of Cisplatin in Lung Adenocarcinoma Cells by Changing Metabolism of 2-Oxoglutarate/Glutamate
   Vasily A. Aleshin et al, 2021, Frontiers in Genetics CrossRef
8. Precise targeting of osteopontin in non-small cell lung cancer spinal metastasis to promote chemosensitivity via a smart hollow nano-platform
   Lei Zhou et al, 2022, Chemical Engineering Journal CrossRef
9. Alternative splicing in ovarian cancer
   Liwei Wei et al, 2024, Cell Communication and Signaling CrossRef